UNI-PHARMA brings SALOSPIR, the first acetylsalicylic acid product launched in Europe in the form of enteric-coated tablets, in 80 – 1,000® mg doses.

T4®, a product for the treatment of thyroid gland diseases, is a specialized product available in 13 different strengths in individualized dosage regimens.

APOTEL®, introduced to the market in 1992, was the world’s first injectable formulation of paracetamol, based on a method of paracetamol solubilization, developed by UNI-PHARMA.

In 1998 UNI-PHARMA obtained the European Patent for injectable paracetamol solutions and paracetamol in combination with other active substances.

During the biggest economic recession that Greece has experienced post-war, the company’s management, headed by Mrs. Ioulia and Mrs. Eirini Tseti, begins the ambitious plan for the creation of its new bioclimatic plant in Kato Kifissia.

The necessary validation works are completed, so as to put basic production lines into operation. The new facilities are a model of bioclimatic implementation, designed to taking full advantage of the climatic conditions for their operation while reducing any energy-consuming process, in full harmony with the natural environment.

The election of the CEO of OFET (Tseti Group of Pharmaceutical Companies), Mrs. Ioulia Tseti to the General Council of the Hellenic Federation of Enterprises is expected to unfold in accordance with her firm belief that we can and must keep the bright minds in our country – after the bleeding of the brain drain and with a view to building a new Greece with strong characteristics of growth and extroversion, based on healthy businesses!

The renovation – maintenance of the first historic UNI-PHARMA factory in Kifissia is completed.

Honorary Award to Mrs. Ioulia and Mrs. Eirini Tseti for their overall contribution to the pharmaceutical industry, health and business from BEST IN PHARMACY 2019.

In March 2019, Mrs. Ioulia Tseti was included in the list of the 30 Most Powerful Women in Greece 2019 of Fortune Hellas magazine.

Tseti Group of Pharmaceutical Companies CEO, Mrs. Ioulia Tseti, achieved an important distinction – overall for our country and the field of sustainable development –, as she was elected President of the first Board of Directors of Global Compact Hellas, which is the Local Network of the UN Global Compact.

Since December 7, 2020, Tsetis Group of Pharmaceutical Companies has been in the leading group of The Most Sustainable Companies in Greece 2020, the 25 companies with the greatest sustainable growth. This is a technical evaluation, carried out by the executives of the Quality Net Foundation Network that makes the Most Sustainable Companies title for the OFET industries, Uni-pharma and InterMed, particularly important.

In the most serious public health crisis the planet has known, Mrs. Ioulia Tseti donates to the Greek and Cypriot health system Unikinon – with chloroquine as an active ingredient, to help patients hospitalized with SARS CoV-2. The production of the drug began almost immediately at the UNI-PHARMA facilities in Kato Kifissia. In the first pandemic wave, chloroquine was cited as a possible successful treatment to tackle the pandemic. Donations amounted to EUR 24 million free Unikinon doses for the (Hellenic) National Health System and 60,000 doses for the Cypriot health system.

Uni-pharma was among the 18 best companies in the country out of a total of 8,000 at the Growth Awards competition, which took place on the evening of Monday, February 17, 2020 at the Athens Concert Hall (Megaron). The Awards, which best highlight healthy entrepreneurship, innovation and excellence in a challenging environment are organized by Grant Thornton and Eurobank.

To UNI-PHARMA’s Repel products, following a vote by iatronet, at the 11th Health Expo Athens.

Environment and Green Development Award of the Athens Chamber of Commerce and Industry to UNI-PHARMA.

Honorary international distinction to Ioulia Tseti from the WHO IS WHO INTERNATIONAL AWARD.

On September 27, 2021, Julia Tseti, via the Kleon Tsetis NPO Foundation, made a large donation of an interactive, 100 seats amphitheater to the School of Pharmacy of the National and Kapodistrian University of Athens, amounting to 120,000 euros. The donation symbolically coincides with the celebration of the 200th anniversary of the Greek Revolution.

Distinctions to Uni-pharma InterMed and to Tsetis Group of Pharmaceutical Companies in general, but also personally to the President and CEO of the Group Ioulia Tseti, at the institutions DIAMONDS OF THE GREEK ECONOMY PROTAGONISTS OF THE GREEK ECONOMY.

This is the highest acclaim of the academic community towards Mrs. Ioulia Tseti, honoring her multiannual research work, but also her ceaseless and tireless actions in aid of the society, the younger generation, and the environment. The investiture ceremony took place in the presence of the Rector’s Authorities, His Eminence the Metropolitan of Arta, professors and students, executives of the Tsetis Group, representatives of the business world and the press.

UNI-PHARMA was distinguished with the ACCI's top business award for Corporate Social Responsibility on Thursday, June 9, 2022, during the Business Awards of the Chamber, at the Peristyle of Zappeion Megaron. The President and CEO of the Tseti Group of Pharmaceutical Companies, Mrs. Ioulia Tseti, as well as the CFO of the Group, Mrs. Eirini Tseti, received the award from the Prime Minister Mr. Kyriakos Mitsotakis himself, in the presence of the President of the ACCI, Mr. Yiannis Bratakos.

Working with UNHCR and UNHCR Representative in Greece, Ms. Maria Clara Martin, to activate targeted actions for refugees. The aim is for these vulnerable groups to be able to integrate into both society and the labor market.